XPC and lung adenocarcinoma: These findings are consistent with translational and in vitro studies inversely linking XPC mRNA expression with response to cisplatin, particularly in lung adenocarcinoma where cisplatin chemotherapy treatment remains a mainstay in locally advanced disease (150).